As a tumor suppressor gene, TP53 alterations were expectedly correlated with the development of progression of HCC (60), and consistent with this, HCC patients with high OAG scores had more altered TP53 and inferior OS. The gene discussed is TP53; the disease is hepatocellular carcinoma.